Ambrx Biopharma Inc. Redeemable Noncontrolling Interest, Equity, Redemption Value
Ambrx Biopharma Inc. had Redeemable Noncontrolling Interest, Equity, Redemption Value of $43.40 million as of 2022-06-30, per its 6-K filed 2022-08-29.
Discontinued › Notes
us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue · last filed 2023-03-30
- 2022-06-30: Redeemable Noncontrolling Interest, Equity, Redemption Value $43.40M.
- 2021-12-31: Redeemable Noncontrolling Interest, Equity, Redemption Value $43.40M.
- 2021-03-31: Redeemable Noncontrolling Interest, Equity, Redemption Value $43.40M.
| Period end | Redeemable Noncontrolling Interest, Equity, Redemption Value |
|---|---|
| 2022-06-30 | $43.40M 6-K · filed 2022-08-29 |
| 2021-12-31 | $43.40M 20-F · filed 2022-04-26 |
| 2021-03-31 | $43.40M 10-K · filed 2023-03-30 |